340 related articles for article (PubMed ID: 33194329)
1. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach.
Rahman MS; Hoque MN; Islam MR; Akter S; Rubayet Ul Alam ASM; Siddique MA; Saha O; Rahaman MM; Sultana M; Crandall KA; Hossain MA
PeerJ; 2020; 8():e9572. PubMed ID: 33194329
[TBL] [Abstract][Full Text] [Related]
2. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
3. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
[TBL] [Abstract][Full Text] [Related]
4. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
5. A new multi-epitope vaccine candidate based on S and M proteins is effective in inducing humoral and cellular immune responses against SARS-CoV-2 variants: an
Samimi Hashjin A; Sardari S; Rostamian M; Ahmadi K; Madanchi H; Khalaj V
J Biomol Struct Dyn; 2023 Oct; ():1-18. PubMed ID: 37874075
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
7. Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2.
Banerjee S; Majumder K; Gutierrez GJ; Gupta D; Mittal B
bioRxiv; 2020 Aug; ():. PubMed ID: 32743567
[TBL] [Abstract][Full Text] [Related]
8. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
[TBL] [Abstract][Full Text] [Related]
9.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
10. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
Jain N; Shankar U; Majee P; Kumar A
Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
[TBL] [Abstract][Full Text] [Related]
11. A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein.
Martin WR; Cheng F
ChemRxiv; 2020 Aug; ():. PubMed ID: 32793875
[TBL] [Abstract][Full Text] [Related]
12. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
Saba AA; Adiba M; Saha P; Hosen MI; Chakraborty S; Nabi AHMN
Comput Biol Med; 2021 Sep; 136():104703. PubMed ID: 34352457
[TBL] [Abstract][Full Text] [Related]
13. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
[TBL] [Abstract][Full Text] [Related]
14. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
Bhatnager R; Bhasin M; Arora J; Dang AS
J Biomol Struct Dyn; 2021 Sep; 39(15):5690-5705. PubMed ID: 32619134
[TBL] [Abstract][Full Text] [Related]
15. A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
Martin WR; Cheng F
J Biomol Struct Dyn; 2022 Sep; 40(15):7099-7113. PubMed ID: 33715598
[TBL] [Abstract][Full Text] [Related]
16. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an
Enayatkhani M; Hasaniazad M; Faezi S; Gouklani H; Davoodian P; Ahmadi N; Einakian MA; Karmostaji A; Ahmadi K
J Biomol Struct Dyn; 2021 May; 39(8):2857-2872. PubMed ID: 32295479
[TBL] [Abstract][Full Text] [Related]
17. Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches.
Saha R; Ghosh P; Burra VLSP
3 Biotech; 2021 Feb; 11(2):47. PubMed ID: 33457172
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2.
Khan MT; Islam MJ; Parihar A; Islam R; Jerin TJ; Dhote R; Ali MA; Laura FK; Halim MA
Inform Med Unlocked; 2021; 24():100578. PubMed ID: 33898733
[TBL] [Abstract][Full Text] [Related]
19. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
[TBL] [Abstract][Full Text] [Related]
20. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases.
Shey RA; Ghogomu SM; Esoh KK; Nebangwa ND; Shintouo CM; Nongley NF; Asa BF; Ngale FN; Vanhamme L; Souopgui J
Sci Rep; 2019 Mar; 9(1):4409. PubMed ID: 30867498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
